Healthcare Check-Up, Q1 2024

Improving capital markets conditions during 2024 should boost M&A activity overall. We are sensing a more optimistic view around transactions beginning to take shape, with more sponsors actively looking to deploy capital and debt financing easier to come by.

Commercial banks have returned to the market after a lull in 2023. We expect to see continuing activity in retail and specialty pharmacy throughout the year as large owners of assets continue to restructure their portfolios. We also expect the hospital, clinic and surgery center sectors to remain active. Significant activity in staffing is likely to be delayed due to continuing post-Covid fallout in shifts and bill rates.

Read the full report here.